About Zhejiang Jiuzhou Pharmaceutical Company

The company was founded in 1998 and is a leading innovative drug CDMO enterprise. It provides global pharmaceutical companies with one-stop drug R&D, production solutions and professional services from pre-clinical CMC, clinical phase I, II, and III, NDA to commercial marketing, and has set a successful example of transformation of traditional domestic generic API companies into innovative drug CDMO companies. The company is a leading, technology-driven CDMO enterprise dedicated to providing one-stop pharmaceutical customized R&D and production (CDMO) services for global pharmaceutical companies, biotechnology companies, scientific research institutions, etc. The company mainly produces and sells specialty APIs and intermediates, and provides customized research and development and production services (CDMO) for new drugs. Corporate honors: It has successively won honors such as the top 100 enterprises in the national pharmaceutical industry, the leading national API export enterprise, the national high-tech enterprise, the national technological innovation demonstration enterprise, the top 100 pharmaceutical industry enterprises in China, the “three” cultivation pilot enterprises in Zhejiang Province, and the “Jiuzhou” brand has won the “Zhejiang Export Famous Brand” and a national service-oriented manufacturing demonstration enterprise. The company won honors such as the top 100 enterprises in China's pharmaceutical industry, the most growing enterprise in the Chinese pharmaceutical industry, the top 20 most competitive listed Chinese pharmaceutical companies, the 9th Zhejiang Provincial People's Government Quality Management Innovation Award, and the “2023 China Pharmaceutical CDMO Enterprise”.